Wendy Recant

3.1k total citations
47 papers, 2.4k citations indexed

About

Wendy Recant is a scholar working on Oncology, Pathology and Forensic Medicine and Cancer Research. According to data from OpenAlex, Wendy Recant has authored 47 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 17 papers in Pathology and Forensic Medicine and 13 papers in Cancer Research. Recurrent topics in Wendy Recant's work include Breast Lesions and Carcinomas (10 papers), Breast Cancer Treatment Studies (9 papers) and Cancer-related Molecular Pathways (4 papers). Wendy Recant is often cited by papers focused on Breast Lesions and Carcinomas (10 papers), Breast Cancer Treatment Studies (9 papers) and Cancer-related Molecular Pathways (4 papers). Wendy Recant collaborates with scholars based in United States and Cyprus. Wendy Recant's co-authors include Everett E. Vokes, Kerstin Stenson, Ezra E.W. Cohen, Walter M. Stadler, Dezheng Huo, Fred Rosen, Ralph R. Weichselbaum, Rosemarie Mick, Ruth Heimann and Carol A. Westbrook and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Wendy Recant

46 papers receiving 2.3k citations

Peers

Wendy Recant
Comparison fields: 5 of 101
  • Oncology 972
  • Molecular Biology 764
  • Cancer Research 559
  • Surgery 539
  • Pathology and Forensic Medicine 502
Replace Claes Silfverswärd with:
Claes Silfverswärd Sweden
Annette Hogg Australia
Thomas J. Ervin United States
M Francoual France
Roberto Giardini Italy
Hyunseok Kang United States
V J Bardou France
W. J. Mooi Netherlands
Madalina Tuluc United States
H D Sinnett United Kingdom
Claes Silfverswärd Sweden View profile →
Citations per field, relative to Wendy Recant
Wendy Recant · 1×
Citations per year, relative to Wendy Recant
Wendy Recant · 1×

Countries citing papers authored by Wendy Recant

Since Specialization
Citations

This map shows the geographic impact of Wendy Recant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wendy Recant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wendy Recant more than expected).

Fields of papers citing papers by Wendy Recant

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wendy Recant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wendy Recant. The network helps show where Wendy Recant may publish in the future.

Co-authorship network of co-authors of Wendy Recant

This figure shows the co-authorship network connecting the top 25 collaborators of Wendy Recant. A scholar is included among the top collaborators of Wendy Recant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wendy Recant. Wendy Recant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 53
2 41
3 41
4 31
5 18
6 2
7 6
8 2
9 71
10 14
11 1
12 143
13
Human breast cancer susceptibility to paclitaxel therapy is independent of Bcl-2 expression.
15
14 64
15 22
16 119
17 91
18 23
19 16
20 17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026